| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/1097-0142(20010915)92:6<1368::AID-CNCR1459>3.0.CO;2-9 |
| P698 | PubMed publication ID | 11745212 |
| P2093 | author name string | M Peters | |
| J A Petrek | |||
| P P Rosen | |||
| R T Senie | |||
| P433 | issue | 6 | |
| P921 | main subject | breast carcinoma | Q18555947 |
| P304 | page(s) | 1368-1377 | |
| P577 | publication date | 2001-09-01 | |
| P1433 | published in | Cancer | Q326041 |
| P1476 | title | Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis | |
| P478 | volume | 92 |
| Q36694923 | 200 Sentinel lymph node biopsies without axillary lymph node dissection -- no axillary recurrences after a 3-year follow-up |
| Q50493188 | A novel method for sentinel lymph node mapping using magnetite in patients with non-small cell lung cancer. |
| Q35525245 | A phase I study to assess the feasibility and oncologic safety of axillary reverse mapping in breast cancer patients |
| Q36843577 | A pilot study using the Gynecologic Cancer Lymphedema Questionnaire (GCLQ) as a clinical care tool to identify lower extremity lymphedema in gynecologic cancer survivors |
| Q33237948 | A pilot, prospective evaluation of a novel alternative for maintenance therapy of breast cancer-associated lymphedema [ISRCTN76522412]. |
| Q37584901 | A prospective study of breast lymphedema: frequency, symptoms, and quality of life |
| Q37083673 | Acupuncture in the treatment of upper-limb lymphedema: results of a pilot study |
| Q35688090 | Adipose-derived stem cells promote lymphangiogenesis in response to VEGF-C stimulation or TGF-β1 inhibition |
| Q50055183 | Analysis of Undesirable Sequelae of Sentinel Node Surgery in Breast Cancer Patients - a Prospective Cohort Study. |
| Q37543409 | Arm/hand swelling and perceived functioning among breast cancer survivors 12 years post-diagnosis: CALGB 79804. |
| Q47662045 | Association Between Precautionary Behaviors and Breast Cancer-Related Lymphedema in Patients Undergoing Bilateral Surgery |
| Q30474173 | Axillary lymph node dissection for breast cancer utilizing Harmonic Focus® |
| Q35163199 | Axillary reverse mapping: five-year experience |
| Q35782088 | Body mass index and breast cancer treatment-related lymphedema |
| Q40098495 | Breast Cancer-Related Lymphedema Risk is Related to Multidisciplinary Treatment and Not Surgery Alone: Results from a Large Cohort Study |
| Q37366477 | Breast and gynecologic cancer-related extremity lymphedema: a review of diagnostic modalities and management options |
| Q37480888 | Breast cancer survivors' experiences of lymphedema-related symptoms |
| Q35490056 | Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations |
| Q34012939 | Breast cancer treatment, BMI, post-op swelling/lymphoedema. |
| Q34023622 | Breast cancer-related lymphedema: Symptoms, diagnosis, risk reduction, and management |
| Q57108719 | Breast cancer-related lymphedema: risk factors, precautionary measures, and treatments |
| Q37790451 | CE ARTICLE: Recognizing and treating upper extremity lymphedema in postmastectomy/lumpectomy patients: A guide for primary care providers |
| Q49571230 | Chirurgische Therapie des Lymphödems – Möglichkeiten und Grenzen |
| Q47367517 | Clinicopathologic features of metastasis in nonsentinel lymph nodes of breast carcinoma patients |
| Q45934179 | Comparative morbidity of axillary lymph node dissection and the sentinel lymph node technique: implications for patients with breast cancer. |
| Q36067725 | Contemporary quality of life issues affecting gynecologic cancer survivors |
| Q30244638 | De-escalation of axillary surgery in early breast cancer |
| Q37210955 | Defining a threshold for intervention in breast cancer-related lymphedema: what level of arm volume increase predicts progression? |
| Q88322660 | Diagnosis and Staging of Lymphedema |
| Q37467956 | Diagnosis and treatment of lymphedema after breast cancer: a population-based study |
| Q47714478 | Diagnostic Accuracy of Clinical Measures Considering Segmental Tissue Composition and Volume Changes of Breast Cancer-Related Lymphedema. |
| Q40083594 | Diagnostic Accuracy of Lymphoscintigraphy for Lymphedema and Analysis of False-Negative Tests |
| Q47569260 | Diagnostic Methods, Risk Factors, Prevention, and Management of Breast Cancer-Related Lymphedema: Past, Present, and Future Directions |
| Q92850546 | Drivers of cost differences between US breast cancer survivors with or without lymphedema |
| Q35141446 | Effect of physical therapy on breast cancer related lymphedema: protocol for a multicenter, randomized, single-blind, equivalence trial |
| Q41691064 | Effectiveness of acupuncture for breast cancer related lymphedema: protocol for a single-blind, sham-controlled, randomized, multicenter trial |
| Q37731446 | Endoscopic nipple sparing mastectomy with immediate implant-based reconstruction versus breast conserving surgery: a long-term study. |
| Q38689150 | Engineering Blood and Lymphatic Microvascular Networks in Fibrin Matrices. |
| Q50495688 | Evaluation of lymph node status in male breast cancer patients: a role for sentinel lymph node biopsy. |
| Q36480513 | Evaluation of the metastatic status of lymph nodes identified using axillary reverse mapping in breast cancer patients |
| Q36172436 | Exercise and the lymphatic system: implications for breast-cancer survivors |
| Q51695522 | Factors influencing breast cancer-related lymphedema volume after intensive decongestive physiotherapy. |
| Q41461921 | Factors influencing response to lymphedema treatment in patients with breast cancer-related lymphedema |
| Q91511304 | Fibrosis and secondary lymphedema: chicken or egg? |
| Q35175930 | Frequency and associated factors of axillary web syndrome in women who had undergone breast cancer surgery: a transversal and retrospective study |
| Q42148875 | Frequency of Early-Stage Lymphedema and Risk Factors in Postoperative Patients with Breast Cancer |
| Q37416098 | Impact of body mass index and weight fluctuation on lymphedema risk in patients treated for breast cancer |
| Q95264085 | Impact of body mass index on long-term surgical outcomes of vascularized lymph node transfer in lymphedema patients |
| Q58613910 | Improving quality of life among latino cancer survivors: Design of a randomized trial of patient navigation |
| Q92710536 | Improving the quality of life of patients with breast cancer-related lymphoedema by lymphaticovenous anastomosis (LVA): study protocol of a multicentre randomised controlled trial |
| Q47123343 | In vivo near-infrared imaging of ErbB2 expressing breast tumors with dual-axes confocal endomicroscopy using a targeted peptide |
| Q38094234 | Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. |
| Q37631642 | Inflammatory Manifestations of Lymphedema |
| Q34199527 | Interleukin-8 reduces post-surgical lymphedema formation by promoting lymphatic vessel regeneration. |
| Q26851370 | Interventions to promote energy balance and cancer survivorship: priorities for research and care |
| Q92558004 | Ischemia and reperfusion injury in superficial inferior epigastric artery-based vascularized lymph node flaps |
| Q35976168 | Late Toxicity of Radiotherapy: A Problem or a Challenge for the Radiation Oncologist? |
| Q34578623 | Life after breast cancer: dealing with lymphoedema |
| Q34004915 | Lifestyle risk factors associated with arm swelling among women with breast cancer |
| Q51020218 | Long-term adjustment of survivors of early-stage breast carcinoma, 20 years after adjuvant chemotherapy. |
| Q33895877 | Long-term risk of medical conditions associated with breast cancer treatment |
| Q90700468 | Lymph Node Radiotherapy Instead of Extended Axillary Surgery - the New Standard? |
| Q36220109 | Lymph Node Transplantation Decreases Swelling and Restores Immune Responses in a Transgenic Model of Lymphedema. |
| Q57123739 | Lymphatic Microsurgical Preventing Healing Approach (LYMPHA) for Prevention of Breast Cancer-Related Lymphedema-a Preliminary Report |
| Q35895537 | Lymphatic function is regulated by a coordinated expression of lymphangiogenic and anti-lymphangiogenic cytokines |
| Q34036806 | Lymphatic lipid transport: sewer or subway? |
| Q28085387 | Lymphatic mapping and lymphedema surgery in the breast cancer patient |
| Q37010325 | Lymphedema and quality of life in breast cancer survivors: the Iowa Women's Health Study. |
| Q90574317 | Lymphedema following breast cancer: The importance of surgical methods and obesity |
| Q37200954 | Lymphedema following treatment for breast cancer: a new approach to an old problem |
| Q57988226 | Lymphedema: experience of a cohort of women with breast cancer followed for 4 years after diagnosis in Victoria, Australia |
| Q55394629 | Machine learning for detection of lymphedema among breast cancer survivors. |
| Q64977732 | Massive Lymphedema Necessitating Disarticulation of Shoulder Joint Following Treatment for Carcinoma Breast. |
| Q26853449 | Mechanical forces and lymphatic transport |
| Q33831892 | Mechanisms of lymphatic regeneration after tissue transfer |
| Q92680741 | Moxibustion as a Therapy for Breast Cancer-Related Lymphedema in Female Adults: A Preliminary Randomized Controlled Trial |
| Q92551197 | Obese patients have higher risk of breast cancer-related lymphedema than overweight patients after breast cancer: a meta-analysis |
| Q33913140 | Obesity increases inflammation and impairs lymphatic function in a mouse model of lymphedema |
| Q33862893 | Older breast cancer survivors: factors associated with self-reported symptoms of persistent lymphedema over 7 years of follow-up. |
| Q41633994 | Optimizing post-acute care in breast cancer survivors: a rehabilitation perspective. |
| Q35720398 | Parametric imaging of the local attenuation coefficient in human axillary lymph nodes assessed using optical coherence tomography |
| Q36143741 | Patterns of Obesity and Lymph Fluid Level during the First Year of Breast Cancer Treatment: A Prospective Study |
| Q38693665 | Persistent impairments 3 years after (neo)adjuvant chemotherapy for breast cancer: results from the MaTox project. |
| Q43046368 | Personalised cancer follow-up: risk stratification, needs assessment or both? |
| Q37813066 | Physical Activity and Breast Cancer Survivorship |
| Q30489696 | Physical Activity and Lymphedema (the PAL trial): assessing the safety of progressive strength training in breast cancer survivors |
| Q35849836 | Possible genetic predisposition to lymphedema after breast cancer |
| Q38947266 | Precautions for breast cancer-related lymphoedema: risk from air travel, ipsilateral arm blood pressure measurements, skin puncture, extreme temperatures, and cellulitis |
| Q81129794 | Preoperative assessment enables the early diagnosis and successful treatment of lymphedema |
| Q38271615 | Preplanning vascularized lymph node transfer with duplex ultrasonography: an evaluation of 3 donor sites |
| Q37119428 | Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements |
| Q37119431 | Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: patient perceptions and precautionary behaviors |
| Q36839514 | Preventative measures for lymphedema: separating fact from fiction |
| Q34175175 | Proactive approach to lymphedema risk reduction: a prospective study |
| Q37436079 | Prospective assessment of lymphedema incidence and lymphedema-associated symptoms following lymph node surgery for melanoma |
| Q34143271 | Prospective assessment of postoperative complications and associated costs following inguinal lymph node dissection (ILND) in melanoma patients. |
| Q36169517 | Psychologic and social sequelae of secondary lymphedema: a review |
| Q33772743 | Quantitative and morphologic change associated with breast cancer-related lymphedema. Comparison of 3.0T MRI to external measures |
| Q37084325 | Race or Resource? BMI, Race, and Other Social Factors as Risk Factors for Interlimb Differences among Overweight Breast Cancer Survivors with Lymphedema. |
| Q34149752 | Radiation therapy causes loss of dermal lymphatic vessels and interferes with lymphatic function by TGF-beta1-mediated tissue fibrosis |
| Q37272657 | Radiation therapy for operable breast cancer: sixty years of progress as seen through the articles published in the journal Cancer |
| Q57161810 | Radiation, inflammation and the immune response in cancer |
| Q47294804 | Randomized controlled trial comparing a low-fat diet with a weight-reduction diet in breast cancer-related lymphedema |
| Q58083444 | Reference values of bioelectrical impedance analysis for detecting breast cancer-related lymphedema |
| Q36208423 | Regulation of adipogenesis by lymphatic fluid stasis: part I. Adipogenesis, fibrosis, and inflammation |
| Q36000031 | Regulation of inflammation and fibrosis by macrophages in lymphedema. |
| Q90103802 | Review of methods and applications of attenuation coefficient measurements with optical coherence tomography |
| Q37677687 | Risk Factors Associated with Lymphedema among Postmenopausal Breast Cancer Survivors after Radical Mastectomy and Axillary Dissection in China |
| Q36744952 | Risk Factors for Arm Lymphedema in a Cohort of Breast Cancer Patients Followed up for 10 Years |
| Q35049954 | Risk factors associated with breast lymphedema |
| Q33880910 | Risk factors for lymphedema in breast cancer survivors, the Iowa Women's Health Study |
| Q34304007 | Risk factors for self-reported arm lymphedema among female breast cancer survivors: a prospective cohort study |
| Q36942792 | Risk factors of lymph edema in breast cancer patients |
| Q35161715 | Risk of breast cancer recurrence in patients receiving manual lymphatic drainage: a hospital-based cohort study |
| Q54372705 | Role of COX-2 in lymphangiogenesis and restoration of lymphatic flow in secondary lymphedema. |
| Q35142670 | Role of physiotherapy and patient education in lymphedema control following breast cancer surgery |
| Q85046372 | Secondary limb lymphedema |
| Q35099230 | Sentinel lymph node biopsy in head and neck cancer |
| Q35805488 | Sentinel lymph node biopsy progress in surgical treatment of cancer |
| Q51951896 | Sequelae of axillary lymph node dissection in older women with stage 1 and 2 breast carcinoma. |
| Q51377416 | Serum fibronectin 1 and ApoE levels increase with risk of lymphedema in Korean breast cancer survivors. |
| Q80999231 | Stretching exercises to reduce symptoms of postoperative neck discomfort after thyroid surgery: prospective randomized study |
| Q34683882 | Surveillance recommendations in reducing risk of and optimally managing breast cancer-related lymphedema |
| Q27001564 | Systematic review of breast cancer related lymphoedema: making a balanced decision to perform an axillary clearance |
| Q34478536 | The Alberta moving beyond breast cancer (AMBER) cohort study: a prospective study of physical activity and health-related fitness in breast cancer survivors. |
| Q91635503 | The Unresolved Pathophysiology of Lymphedema |
| Q36385197 | The benefits and limitations of sentinel lymph node biopsy |
| Q36905679 | The effect of prospective monitoring and early physiotherapy intervention on arm morbidity following surgery for breast cancer: a pilot study |
| Q35866958 | The efficacy of arm node preserving surgery using axillary reverse mapping for preventing lymphedema in patients with breast cancer |
| Q36630415 | The epidemiology of arm and hand swelling in premenopausal breast cancer survivors |
| Q35277965 | The labour market, psychosocial outcomes and health conditions in cancer survivors: protocol for a nationwide longitudinal survey 2 and 5 years after cancer diagnosis (the VICAN survey). |
| Q92834900 | The legacy of lymphedema: Impact on nursing practice and vascular access |
| Q40263354 | The rationale, design, and implementation of the American Cancer Society's studies of cancer survivors |
| Q34396585 | The use of rehabilitation among patients with breast cancer: a retrospective longitudinal cohort study |
| Q47200516 | Therapeutic effects of hyaluronidase on acquired lymphedema using a newly developed mouse limb model |
| Q38131800 | Tissue engineering and regeneration of lymphatic structures |
| Q35780746 | Toll-like receptor deficiency worsens inflammation and lymphedema after lymphatic injury |
| Q42129574 | Topical bFGF Improves Secondary Lymphedema through Lymphangiogenesis in a Rat Tail Model |
| Q37476817 | Toward nodal staging of axillary lymph node basins through intradermal administration of fluorescent imaging agents |
| Q48039896 | Treatment-related risk factors for arm lymphedema among long-term breast cancer survivors |
| Q38656126 | Upper limb lymphedema in breast cancer patients in the era of Z0011, sentinel lymph node biopsy and breast conservation |
| Q38001373 | Upper-body morbidity after breast cancer: incidence and evidence for evaluation, prevention, and management within a prospective surveillance model of care. |
| Q38932021 | Usability and feasibility of health IT interventions to enhance Self-Care for Lymphedema Symptom Management in breast cancer survivors |
| Q37664022 | Use of sentinel lymph node biopsy to select patients for local-regional therapy after neoadjuvant chemotherapy |
| Q92957676 | VE-Cadherin Is Required for Lymphatic Valve Formation and Maintenance |
| Q35684387 | Which patients need an axillary clearance after sentinel node biopsy? |
Search more.